BioNTech SE (BNTX)
100.60
+1.85
(+1.87%)
USD |
NASDAQ |
May 31, 16:00
100.51
-0.09
(-0.09%)
After-Hours: 20:00
BioNTech Cash from Investing (Quarterly): -2.503B for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -2.503B |
| December 31, 2023 | -2.891B |
| September 30, 2023 | -1.337B |
| June 30, 2023 | -2.511B |
| March 31, 2023 | -789.85M |
| December 31, 2022 | -163.85M |
| September 30, 2022 | -95.99M |
| June 30, 2022 | -99.88M |
| March 31, 2022 | 322.50M |
| December 31, 2021 | -120.12M |
| September 30, 2021 | -479.66M |
| Date | Value |
|---|---|
| June 30, 2021 | -35.92M |
| March 31, 2021 | -34.10M |
| December 31, 2020 | -112.74M |
| September 30, 2020 | -25.42M |
| June 30, 2020 | -10.76M |
| March 31, 2020 | -16.44M |
| December 31, 2019 | -11.88M |
| September 30, 2019 | -23.14M |
| June 30, 2019 | -13.74M |
| March 31, 2019 | -37.68M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-2.891B
Minimum
Dec 2023
322.50M
Maximum
Mar 2022
-547.66M
Average
-97.93M
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc | 1.732B |
| Moderna Inc | 118.00M |
| GSK PLC | -188.99M |
| NuCana PLC | 0.0545M |
| Autolus Therapeutics PLC | -0.533M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -344.65M |
| Cash from Financing (Quarterly) | -8.472M |
| Free Cash Flow | 5.344B |
| Free Cash Flow Per Share (Quarterly) | -2.051 |
| Free Cash Flow to Equity (Quarterly) | -506.34M |
| Free Cash Flow to Firm (Quarterly) | -493.35M |
| Free Cash Flow Yield | 22.10% |